Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Queensland Health
Johnson and Johnson

Generated: June 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,083,778

« Back to Dashboard

Title:Ultrasound contrast agents and methods of making and using them
Abstract: Gas or air filled microbubble suspensions in aqueous phases usable as imaging contrast agents in ultrasonic echography. They contain surfactants and, optionally, hydrophilic stabilizers. The surfactants can be in the form of liposomes. The suspensions are obtained by exposing the surfactants to air or a gas before or after admixing with an aqueous phase. One can impart outstanding resistance against collapse under pressure to these gas-filled microbubbles used as contrast agents in ultrasonic echography by using as fillers gases whose solubility in water, expressed in liter of gas by liter of water under standard conditions, divided by the square root of the molecular weight does not exceed 0.003. Contrast agents with particular mixtures of gases are also disclosed that have advantageous properties.
Inventor(s): Schneider; Michel (Troinex, CH), Yan; Feng (Carouge, CH), Garcel, legal representative; Nadine (Ambilly, FR), Puginier; Jerome (Le Chable-Beaumont, FR), Barrau; Marie-Bernadette (Geneve, CH), Bussat; Philippe (Feigeres, FR), Hybl; Eva (Heidelberg, DE), Bichon; Daniel (Montpellier, FR), Grenier, deceased; Pascal (Ambilly, FR)
Assignee: Bracco International B.V. (Amsterdam, NL)
Filing Date:Mar 12, 2003
Application Number:10/385,473
Claims:1. An ultrasound contrast agent comprising an aqueous solution and phospholipid stabilized microbubbles, the phospholipid stabilized microbubbles containing gas comprising a halogenated hydrocarbon wherein the gas is stabilized by phospholipids in lamellar or laminar form at the gas/liquid interface.

2. The ultrasound contrast agent of claim 1 wherein the gas further comprises nitrogen.

3. The ultrasound contrast agent of claim 1 wherein the phospholipids comprise saturated synthetic lecithin.

4. The ultrasound contrast agent of claim 1 wherein the phospholipids comprise dipalmitoylphosphatidylcholine.

5. The ultrasound contrast agent of claim 1 wherein the phospholipids comprise dipalmitoylphosphatidic acid.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Harvard Business School
US Army
Argus Health
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.